Summary

The nutraceutical ingredients market is projected to grow from USD 108.33 billion in 2026 to USD 161.53 billion in 2031, at a CAGR of 7.3%. Expanding use of amino acids in sports and specialized nutrition is expected to drive market growth Amino acids are increasingly incorporated into sports nutrition, dietary supplements, and specialized nutrition products, particularly formulations designed to support muscle recovery, physical performance, and protein intake. Branched-chain amino acids, essential amino acids, non-essential amino acids, and specialty amino acids are used across a range of formulations, with branched-chain amino acids particularly common in sports nutrition products targeting exercise performance and recovery. Their availability in standardized and high-purity forms enables manufacturers to develop products in powders, capsules, tablets, and functional beverages. In addition, advances in fermentation-based production are improving the efficiency, consistency, and scalability of amino acid manufacturing, supporting the availability of ingredients for different formulation requirements. The continued development of sports nutrition, active-aging, and specialized nutrition products is further broadening the use of amino acids across nutraceutical applications. Established nutritional and functional benefits of animal-based nutraceutical ingredients to support market growth. By source, the animal-based segment accounts for a significant share of the nutraceutical ingredients market, supported by the high nutritional value, bioavailability, and established functional benefits of animal-derived ingredients. Animal-based sources provide a range of high-value nutrients and bioactive compounds used in products targeting joint, bone, muscle, cardiovascular, skin, and cognitive health. Their established use in sports nutrition is further supporting demand, particularly for protein-based products such as protein powders, meal replacements, and recovery beverages. Animal-derived ingredients also have an important role in infant and early-life nutrition, where dairy proteins and specialized components are used in formulations designed to support growth and development. In addition, their use in medical and specialized nutrition is supported by their nutritional quality and established scientific evidence, particularly in products addressing malnutrition, muscle loss, recovery, and age-related nutritional needs. These established applications across sports, infant, medical, and healthy-aging nutrition continue to sustain demand for animal-based nutraceutical ingredients. North America is expected to account for a significant share of the nutraceutical ingredients market due to strong consumer demand and an established nutraceutical industry. North America is expected to account for a significant share of the nutraceutical ingredients market, supported by strong consumption of dietary supplements, high consumer awareness of preventive healthcare, and growing demand for functional nutrition products. The region has a well-established market for dietary supplements used across immunity, heart health, digestive wellness, sports nutrition, and healthy aging applications. High disposable incomes and healthcare spending support consumer willingness to spend on premium wellness, nutrition, and health products. In addition, the established functional food and beverage market, including protein-fortified foods, probiotic products, functional dairy products, energy and sports drinks, and fortified beverages, creates consistent demand for nutraceutical ingredients. The growing aging population is further increasing demand for products supporting joint, bone, cognitive, cardiovascular, and healthy aging needs, while the strong sports and active nutrition industry supports the use of protein ingredients, amino acids, and functional nutrition ingredients. In-depth interviews were conducted with chief executive officers (CEOs), directors, and managers from various key organizations operating in the nutraceutical ingredients market. ・ By Company Type: Tier 1 – 25%, Tier 2 – 45%, and Tier 3 – 30% ・ By Designation: Directors– 35%, C-level – 40%, Others – 25% ・ By Region: North America – 20%, Europe – 25%, Asia Pacific – 35%, South America – 15%, and Rest of the World –5% Prominent companies in the nutraceutical ingredients market include Cargill, Incorporated (US), ADM (US), International Flavors & Fragrances Inc. (US), BASF SE (Germany), Glanbia PLC (Ireland), Arla Foods amba (Denmark), dsm-firmenich (Netherlands), Ingredion Incorporated (US), Tate & Lyle PLC (UK), Roquette Frères (France), Associated British Foods PLC (UK), Fonterra Co-operative Group Limited (New Zealand), Kerry Group PLC (Ireland), Novonesis Group (Denmark), Balchem Corporation (US), Ajinomoto Co., Inc. (Japan), Divi's Laboratories Limited (India), Kemin Industries (US), GELITA AG (Germany), BENEO GmbH (Germany), Cosucra Groupe Warcoing SA (Belgium), Conagen Inc. (US), Sarshika Pharmachem LLP (India), Canurta Naturals USA (US), and EVANIUM (US). Research Coverage This research report categorizes the nutraceutical ingredients market, by ingredient type (functional proteins, omega-3 fatty acids, probiotics, prebiotics, fibers & specialty carbohydrates, vitamins [vitamin A, vitamin B, vitamin C, vitamin D, vitamin E, and others], minerals [calcium, magnesium, iron, zinc, other minerals], amino acids [branched-chain amino acids, essential amino acids, non-essential amino acids, specialty amino acids], carotenoids, other types), source (plant-based, animal-based, microbial-based, synthetics), function (nutritional support, digestive health, immune health, cardiovascular health, bone & joint health, cognitive & mental health, sports & performance, weight management, others), and application (human nutrition [dietary supplements, functional foods, functional beverages, medical & specialized nutrition, infant & early-life nutrition], animal nutrition [companion animal nutrition, livestock nutrition, aquaculture nutrition, other animal nutrition]), and region (North America, Europe, Asia Pacific, South America, RoW). The report’s scope encompasses detailed information on the major factors, including drivers, restraints, challenges, and opportunities, which influence the growth of the nutraceutical ingredients industry. A thorough analysis of the key industry players was done to provide insights into their business, services, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments associated with the nutraceutical ingredients market. This report provides a competitive analysis of emerging startups in the nutraceutical ingredients market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscape, among others. Reasons to Buy This Report The report provides market leaders/new entrants with information on the closest approximations of revenue numbers for the overall nutraceutical ingredients and their subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. The report provides insights into the following pointers: ・ Analysis of key drivers (increasing adoption of dietary supplements and targeted health products, Growing demand for fortified and functionally enhanced foods and beverages), restraints (higher costs associated with fortification and functional formulation, stringent regulatory requirements and health-claim restrictions), opportunities (widespread micronutrient deficiencies and continued use of fortification and supplementation, growing demand for preventive and healthy aging nutrition), and challenges (advancements in delivery technologies enhancing bioavailability and stability of nutraceutical ingredients, variability and quality-control challenges for botanical and natural ingredients) ・ Product Development/Innovation: Detailed insights into research & development activities and new product launches in the nutraceutical ingredients market ・ Market Development: Comprehensive information about lucrative markets, by offering analysis of nutraceutical ingredients across varied regions ・ Market Diversification: Exhaustive information about product sources, geographies, recent developments, and investments in the nutraceutical ingredients market ・ Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as Cargill, Incorporated (US), ADM (US), International Flavors & Fragrances Inc. (US), BASF SE (Germany), Glanbia PLC (Ireland), Arla Foods amba (Denmark), dsm-firmenich (Netherlands), Ingredion Incorporated (US), Tate & Lyle PLC (UK), Roquette Frères (France), Associated British Foods PLC (UK), Fonterra Co-operative Group Limited (New Zealand), Kerry Group PLC (Ireland), Novonesis Group (Denmark), Balchem Corporation (US) and other players in the nutraceutical ingredients market

ページTOPに戻る

Table of Contents

1 INTRODUCTION 47
1.1 STUDY OBJECTIVES 47
1.2 MARKET DEFINITION 47
1.3 STUDY SCOPE 48
1.3.1 INCLUSIONS AND EXCLUSIONS 49
1.3.2 YEARS CONSIDERED 50
1.4 CURRENCY CONSIDERED 51
1.5 UNIT CONSIDERED 51
1.6 STAKEHOLDERS 52
1.7 SUMMARY OF CHANGES 53
2 EXECUTIVE SUMMARY 54
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 54
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 55
2.3 DISRUPTIVE TRENDS IN NUTRACEUTICAL INGREDIENTS MARKET 56
2.4 HIGH-GROWTH SEGMENTS 57
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 58
3 PREMIUM INSIGHTS 59
3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN NUTRACEUTICAL INGREDIENTS MARKET 59
3.2 NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE AND REGION 60
3.3 NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE 61
3.4 NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE 62
3.5 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION 62
3.6 NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY 63
4 MARKET OVERVIEW 64
4.1 INTRODUCTION 64
4.2 MARKET DYNAMICS 65
4.2.1 DRIVERS 66
4.2.1.1 Increasing adoption of dietary supplements and targeted health products 66
4.2.1.2 Growing demand for fortified and functionally enhanced foods and beverages 66
4.2.1.3 Rising incidence of chronic diseases 67
4.2.2 RESTRAINTS 68
4.2.2.1 High Cost and price volatility of nutraceutical ingredients 68
4.2.2.2 Stringent regulatory requirements and health-claim restrictions 69
4.2.3 OPPORTUNITIES 69
4.2.3.1 Widespread micronutrient deficiencies and continued use of fortification and supplementation 69
4.2.3.2 Growing demand for preventive and healthy aging nutrition 70
4.2.3.3 Advancements in delivery technologies enhancing bioavailability and stability of nutraceutical ingredients 70
4.2.4 CHALLENGES 71
4.2.4.1 Variability and quality-control challenges for botanical and natural ingredients 71
4.2.4.2 Supply chain disruptions and availability of nutraceutical raw materials 72
4.3 UNMET NEEDS AND WHITE SPACES 73
4.3.1 UNMET NEEDS IN NUTRACEUTICAL INGREDIENTS MARKET 73
4.3.2 WHITE SPACE OPPORTUNITIES 75
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 78
4.4.1 INTERCONNECTED MARKETS 78
4.4.2 CROSS-SECTOR OPPORTUNITIES 79
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 81
4.5.1 KEY MOVES AND STRATEGIC FOCUS 81
5 INDUSTRY TRENDS 84
5.1 INTRODUCTION 84
5.2 PORTER’S FIVE FORCES ANALYSIS 85
5.2.1 THREAT OF NEW ENTRANTS 86
5.2.2 THREAT OF SUBSTITUTES 87
5.2.3 BARGAINING POWER OF SUPPLIERS 87
5.2.4 BARGAINING POWER OF BUYERS 88
5.2.5 INTENSITY OF COMPETITIVE RIVALRY 89
5.3 MACROECONOMIC INDICATORS 89
5.3.1 GLOBAL HEALTHCARE EXPENDITURE 89
5.3.2 REAL HOUSEHOLD INCOME 91
5.4 VALUE CHAIN ANALYSIS 92
5.4.1 RAW MATERIAL SOURCING 92
5.4.2 EXTRACTION & PROCESSING 93
5.4.3 INGREDIENT MANUFACTURING & STANDARDIZATION 93
5.4.4 QUALITY ASSURANCE, R&D & REGULATORY 93
5.4.5 COMMERCIALIZATION & DISTRIBUTION 93
5.4.6 INGREDIENT APPLICATION 93
5.5 ECOSYSTEM ANALYSIS 94
5.5.1 DEMAND SIDE 94
5.5.2 SUPPLY SIDE 94
5.6 PRICING ANALYSIS 96
5.6.1 INDICATIVE PRICE TREND AMONG MARKET PLAYERS 96
5.6.2 AVERAGE SELLING PRICE TREND, BY INGREDIENT TYPE 97
5.6.3 AVERAGE SELLING PRICE TREND, BY REGION 98
5.7 TRADE ANALYSIS 99
5.7.1 TRADE ANALYSIS OF HS CODE 2936: PROVITAMINS AND VITAMINS 100
5.7.1.1 Export Trends of HS Code 2936 (2021–2025) 100
5.7.1.2 Import Trends under HS Code 2936 (2021–2025) 101
5.8 KEY CONFERENCES & EVENTS 104
5.9 TRENDS IMPACTING CUSTOMERS’ BUSINESSES 105
5.10 INVESTMENT AND FUNDING SCENARIO 106
5.11 CASE STUDY ANALYSIS 107
5.11.1 DSM-FIRMENICH SUPPORTED KOREA EUNDAN’S TRANSITION TO ALGAL OMEGA-3 107
5.11.2 KERRY – BC30 PROBIOTIC IN FUNCTIONAL HOT BEVERAGE 107
5.11.3 INGREDION – VITESSENCE PULSE 1853 PEA PROTEIN IN VEGAN BEVERAGE 108
5.12 IMPACT OF US TARIFF – NUTRACEUTICAL INGREDIENTS MARKET 108
5.12.1 INTRODUCTION 108
5.12.2 PRICE IMPACT ANALYSIS 109
5.12.3 IMPACT ON COUNTRY/REGION 110
5.12.3.1 US 110
5.12.3.2 Europe 110
5.12.3.3 Asia Pacific 110
5.12.4 IMPACT ON END-USE INDUSTRIES 110
6 REGULATORY AND SUSTAINABILITY LANDSCAPE 112
6.1 INTRODUCTION 112
6.2 REGIONAL REGULATIONS AND COMPLIANCE 112
6.2.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 113
6.2.2 INDUSTRY STANDARDS 118
6.3 SUSTAINABILITY INITIATIVES 119
6.3.1 SUSTAINABLE AND RESPONSIBLE SOURCING 120
6.3.2 RESOURCE EFFICIENCY AND LOW-CARBON MANUFACTURING 121
6.3.3 CIRCULAR ECONOMY AND SUSTAINABLE PRODUCTION 121
6.3.4 CIRCULAR ECONOMY AND FOOD WASTE REDUCTION 122
6.4 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 123
6.5 CERTIFICATIONS, LABELING, ECO-STANDARDS 125
7 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 129
7.1 INTRODUCTION 129
7.2 KEY TECHNOLOGIES 129
7.2.1 ADVANCED EXTRACTION & PURIFICATION TECHNOLOGIES 129
7.2.2 PRECISION FERMENTATION & ADVANCED BIOPROCESSING 130
7.2.3 ENCAPSULATION & ADVANCED DELIVERY SYSTEMS 130
7.3 COMPLEMENTARY TECHNOLOGIES 130
7.3.1 ADVANCED ANALYTICAL & CHARACTERIZATION TECHNOLOGIES 130
7.3.2 NANOTECHNOLOGY & ADVANCED FORMULATION TECHNOLOGIES 131
7.3.3 AUTOMATION, PROCESS MONITORING & DIGITAL MANUFACTURING TECHNOLOGIES 131
7.4 ADJACENT TECHNOLOGIES 131
7.4.1 SYNTHETIC BIOLOGY & BIOINFORMATICS 131
7.4.2 PERSONALIZED NUTRITION & DIGITAL HEALTH TECHNOLOGIES 132
7.4.3 ADVANCED FOOD PROCESSING & 3D FOOD-PRINTING TECHNOLOGIES 132
7.5 TECHNOLOGY/PRODUCT ROADMAP 132
7.5.1 SHORT-TERM | OPTIMIZATION OF EXTRUSION PROCESSES AND CLEAN-LABEL PRODUCT DEVELOPMENT 132
7.5.2 MID-TERM | INTELLIGENT MANUFACTURING AND COMMERCIALIZATION OF NEXT-GENERATION PROTEIN INGREDIENTS 133
7.5.3 LONG-TERM | AUTONOMOUS AI-DRIVEN MANUFACTURING AND SUSTAINABLE PROTEIN INNOVATION 133
7.6 PATENT ANALYSIS 133
7.6.1 LIST OF MAJOR PATENTS 135
7.7 FUTURE APPLICATIONS 135
7.7.1 PERSONALIZED & PRECISION NUTRITION 136
7.7.2 FUNCTIONAL & SPECIALIZED NUTRITION PRODUCTS 137
7.8 IMPACT OF GENERATIVE AI ON NUTRACEUTICAL INGREDIENTS MARKET 137
7.8.1 INTRODUCTION 137
7.8.2 TOP USE CASES AND MARKET POTENTIAL 138
7.8.3 BEST PRACTICES IN NUTRACEUTICAL INGREDIENTS INDUSTRY 138
7.8.4 CASE STUDIES OF AI IMPLEMENTATION IN NUTRACEUTICAL INGREDIENTS MARKET 139
7.8.5 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 140
7.8.6 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN NUTRACEUTICAL INGREDIENTS MARKET 141
7.9 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 141
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 142
8.1 INTRODUCTION 142
8.2 DECISION-MAKING PROCESS 142
8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 144
8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 144
8.3.2 BUYING CRITERIA 146
8.4 ADOPTION BARRIERS AND INTERNAL CHALLENGES 148
8.5 UNMET NEEDS OF VARIOUS END-USE INDUSTRIES 149
8.6 MARKET PROFITABILITY 151
9 NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTION 152
9.1 INTRODUCTION 152
9.2 NUTRITIONAL SUPPORT 153
9.3 DIGESTIVE HEALTH 153
9.4 IMMUNE HEALTH 154
9.5 CARDIOVASCULAR HEALTH 154
9.6 BONE & JOINT HEALTH 155
9.7 COGNITIVE & MENTAL HEALTH 156
9.8 SPORTS & PERFORMANCE 156
9.9 WEIGHT MANAGEMENT 157
9.10 OTHERS (BEAUTY & HEALTHY AGING, ETC.) 157
10 NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE 158
10.1 INTRODUCTION 159
10.2 FUNCTIONAL PROTEINS 162
10.2.1 NUTRITIONAL FUNCTIONALITY AND EXPANDING APPLICATIONS 162
10.3 OMEGA-3 FATTY ACIDS 164
10.3.1 GROWING DEMAND FOR CARDIOVASCULAR, COGNITIVE, AND PREVENTIVE NUTRITION 164
10.4 PROBIOTICS 166
10.4.1 EXPANDING APPLICATIONS IN GUT HEALTH AND FUNCTIONAL NUTRITION 166
10.5 PREBIOTICS 168
10.5.1 SUPPORTING GUT MICROBIOME HEALTH AND FUNCTIONAL NUTRITION 168
10.6 FIBERS & SPECIALTY CARBOHYDRATES 170
10.6.1 EXPANDING ROLE IN DIGESTIVE HEALTH AND PRODUCT FORMULATION 170
10.7 VITAMINS 172
10.7.1 ESSENTIAL MICRONUTRIENTS SUPPORTING PREVENTIVE AND SPECIALIZED NUTRITION 172
10.7.2 VITAMIN A 174
10.7.3 VITAMIN B 175
10.7.4 VITAMIN C 176
10.7.5 VITAMIN D 177
10.7.6 VITAMIN E 178
10.7.7 OTHER VITAMINS (MULTIVITAMIN, ETC.) 179
10.8 MINERALS 180
10.8.1 ESSENTIAL MICRONUTRIENTS ACROSS SUPPLEMENTATION, FORTIFICATION, AND SPECIALIZED NUTRITION 180
10.8.2 CALCIUM 183
10.8.3 MAGNESIUM 184
10.8.4 IRON 185
10.8.5 ZINC 186
10.8.6 OTHER MINERALS 187
10.9 AMINO ACIDS 188
10.9.1 EXPANDING ROLE IN TARGETED NUTRITION, SPORTS PERFORMANCE, AND METABOLIC SUPPORT 188
10.9.2 BRANCHED-CHAIN AMINO ACIDS 191
10.9.3 ESSENTIAL AMINO ACIDS 192
10.9.4 NON-ESSENTIAL AMINO ACIDS 193
10.9.5 SPECIALTY AMINO ACIDS 194
10.10 CAROTENOIDS 195
10.10.1 NATURAL PIGMENTS WITH EXPANDING NUTRITIONAL AND FUNCTIONAL APPLICATIONS 195
10.11 OTHER INGREDIENT TYPES 197
11 NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE 200
11.1 INTRODUCTION 201
11.2 PLANT-BASED 202
11.2.1 EXPANSION OF PLANT-BASED SUPPLY AND PROCESSING CAPACITY TO DRIVE NUTRACEUTICAL INGREDIENT MARKET GROWTH 202
11.3 ANIMAL-BASED 204
11.3.1 GROWING DEMAND FOR HIGH-PROTEIN AND BIOACTIVE INGREDIENTS TO DRIVE ANIMAL-BASED INGREDIENT GROWTH 204
11.4 MICROBIAL-BASED 205
11.4.1 EXPANSION OF MICROBIAL-DERIVED INGREDIENTS AND FERMENTATION-BASED PRODUCTION TO DRIVE MARKET GROWTH 205
11.5 SYNTHETICS 207
11.5.1 CONSISTENT QUALITY AND SCALABLE PRODUCTION OF SYNTHETIC INGREDIENTS TO SUPPORT MARKET GROWTH 207
12 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION 209
12.1 INTRODUCTION 210
12.2 HUMAN NUTRITION 212
12.2.1 DIETARY SUPPLEMENTS 213
12.2.1.1 Dietary supplements remain largest application for nutraceutical ingredients due to their established consumer acceptance 213
12.2.2 FUNCTIONAL FOODS 214
12.2.2.1 Growing health-conscious consumption is driving nutraceutical ingredient adoption in functional foods 214
12.2.3 FUNCTIONAL BEVERAGES 215
12.2.3.1 Demand for convenient wellness products is accelerating nutraceutical ingredient use in beverages 215
12.2.4 MEDICAL & SPECIALIZED NUTRITION 216
12.2.4.1 Rising demand for targeted nutrition is supporting use of specialty nutraceutical ingredients 216
12.2.5 INFANT & EARLY-LIFE NUTRITION 217
12.2.5.1 Greater focus on early-life health is driving demand for high-quality nutraceutical ingredients 217
12.3 ANIMAL NUTRITION 218
12.3.1 COMPANION ANIMAL NUTRITION 220
12.3.1.1 Pet humanization is accelerating demand for nutraceutical ingredients in companion animal nutrition 220
12.3.2 LIVESTOCK NUTRITION 221
12.3.2.1 Reduced reliance on antibiotics is driving nutraceutical adoption in livestock nutrition 221
12.3.3 AQUACULTURE NUTRITION 222
12.3.3.1 Growing aquaculture production is increasing demand for functional nutrition ingredients 222
12.3.4 OTHER ANIMAL NUTRITION 223
12.3.4.1 Specialized animal health needs are creating demand for targeted nutraceutical ingredients 223
13 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION 225
13.1 INTRODUCTION 226
13.2 NORTH AMERICA 229
13.2.1 US 238
13.2.1.1 Strong supplement penetration and rising demand for functional nutrition 238
13.2.2 CANADA 245
13.2.2.1 Growing demand for natural products supports market expansion 245
13.2.3 MEXICO 251
13.2.3.1 Expanding preventive nutrition demand and broadening supplement ecosystem 251
13.3 EUROPE 258
13.3.1 GERMANY 266
13.3.1.1 High food supplement penetration and demand for micronutrients support market growth 266
13.3.2 UK 273
13.3.2.1 Established food supplement use and regulatory support for innovative ingredients support market growth 273
13.3.3 FRANCE 279
13.3.3.1 Established supplement market and growing demand for targeted nutrition support market growth 279
13.3.4 ITALY 286
13.3.4.1 Large supplement product base and broad use of nutritional ingredients support market growth 286
13.3.5 SPAIN 292
13.3.5.1 Established supplement regulation and broad nutritional ingredient applications support market growth 292
13.3.6 REST OF EUROPE 298
13.3.6.1 Expanding food supplement use and regulatory harmonization support market opportunities 298
13.4 ASIA PACIFIC 305
13.4.1 CHINA 314
13.4.1.1 Expanding health food formulation and diversification of nutritional products support market growth 314
13.4.2 INDIA 321
13.4.2.1 Large agricultural base and expanding nutraceutical ecosystem support market growth 321
13.4.3 JAPAN 328
13.4.3.1 Rapid population aging and preventive healthcare culture drive demand for functional ingredients 328
13.4.4 AUSTRALIA & NEW ZEALAND 335
13.4.4.1 Strong supplement adoption and export-oriented health product ecosystem support nutraceutical ingredient demand 335
13.4.5 REST OF ASIA PACIFIC 342
13.5 SOUTH AMERICA 348
13.5.1 BRAZIL 357
13.5.1.1 Strong supplement penetration and rapid expansion of protein and vitamin ingredients 357
13.5.2 ARGENTINA 364
13.5.2.1 Growing demand for targeted nutrition and specialty nutraceutical ingredients 364
13.5.3 REST OF SOUTH AMERICA 370
13.5.3.1 Emerging consumer awareness and diversification of functional nutrition 370
13.6 REST OF THE WORLD (ROW) 377
13.6.1 MIDDLE EAST 385
13.6.1.1 Rising nutrition-related health needs and preventive healthcare focus 385
13.6.2 AFRICA 391
13.6.2.1 Nutritional needs and food fortification programs create structural ingredient demand 391
14 COMPETITIVE LANDSCAPE 398
14.1 OVERVIEW 398
14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2026 399
14.3 BRAND/PRODUCT COMPARISON 401
14.3.1 CARGILL, INCORPORATED (EPICOR) 402
14.3.2 ADM (FIBERSOL) 402
14.3.3 GLANBIA PLC (FERRIUP) 402
14.3.4 DSM-FIRMENICH (PEPTOPRO) 402
14.3.5 ROQUETTE FRÈRES (NUTRALYS) 402
14.4 REVENUE ANALYSIS, 2023–2025 402
14.5 COMPANY VALUATION AND FINANCIAL METRICS 404
14.5.1 COMPANY VALUATION 404
14.5.2 EV/EBITDA 405
14.6 MARKET SHARE ANALYSIS, 2025 405
14.7 NUTRACEUTICAL INGREDIENTS MARKET COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 407
14.7.1 STARS 408
14.7.2 EMERGING LEADERS 408
14.7.3 PERVASIVE PLAYERS 408
14.7.4 PARTICIPANTS 408
14.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 410
14.7.5.1 Company footprint 410
14.7.5.2 Region footprint 410
14.7.5.3 Ingredient type footprint 411
14.7.5.4 Source footprint 412
14.7.5.5 Application footprint 413
14.8 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2025 414
14.8.1 PROGRESSIVE COMPANIES 414
14.8.2 RESPONSIVE COMPANIES 414
14.8.3 DYNAMIC COMPANIES 414
14.8.4 STARTING BLOCKS 414
14.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 416
14.8.5.1 Key startups/SMEs 416
14.8.5.2 Competitive benchmarking of key startups/SMEs 417
14.9 COMPETITIVE SCENARIO 418
14.9.1 PRODUCT LAUNCHES 418
14.9.2 DEALS 420
14.9.3 EXPANSIONS 422
15 COMPANY PROFILES 425
15.1 KEY PLAYERS 425
15.1.1 CARGILL, INCORPORATED 425
15.1.1.1 Business overview 425
15.1.1.2 Products offered 426
15.1.1.3 Recent developments 429
15.1.1.3.1 Product launches 429
15.1.1.3.2 Deals 430
15.1.1.3.3 Expansions 431
15.1.1.3.4 Other developments 433
15.1.1.4 MnM view 434
15.1.1.4.1 Right to win 434
15.1.1.4.2 Strategic choices 434
15.1.1.4.3 Weaknesses and competitive threats 434
15.1.2 ADM 435
15.1.2.1 Business overview 435
15.1.2.2 Products offered 436
15.1.2.3 Recent developments 441
15.1.2.3.1 Product launches 441
15.1.2.3.2 Deals 441
15.1.2.3.3 Expansions 443
15.1.2.3.4 Other developments 444
15.1.2.4 MnM view 445
15.1.2.4.1 Right to win 445
15.1.2.4.2 Strategic choices 446
15.1.2.4.3 Weaknesses and competitive threats 446
15.1.3 INTERNATIONAL FLAVORS & FRAGRANCES INC. 447
15.1.3.1 Business overview 447
15.1.3.2 Products offered 448
15.1.3.3 Recent developments 451
15.1.3.3.1 Product launches 451
15.1.3.3.2 Deals 453
15.1.3.3.3 Expansions 454
15.1.3.3.4 Other developments 456
15.1.3.4 MnM view 456
15.1.3.4.1 Right to win 456
15.1.3.4.2 Strategic choices 457
15.1.3.4.3 Weaknesses and competitive threats 457
15.1.4 BASF 458
15.1.4.1 Business overview 458
15.1.4.2 Products offered 459
15.1.4.3 Recent developments 463
15.1.4.3.1 Product launches 463
15.1.4.3.2 Deals 463
15.1.4.3.3 Expansions 464
15.1.4.3.4 Other developments 465
15.1.4.4 MnM view 466
15.1.4.4.1 Right to win 466
15.1.4.4.2 Strategic choices 466
15.1.4.4.3 Weaknesses and competitive threats 466
15.1.5 GLANBIA PLC 467
15.1.5.1 Business overview 467
15.1.5.2 Products offered 468
15.1.5.3 Recent developments 472
15.1.5.3.1 Product launches 472
15.1.5.3.2 Deals 473
15.1.5.3.3 Expansions 474
15.1.5.3.4 Other developments 475
15.1.5.4 MnM view 475
15.1.5.4.1 Right to win 475
15.1.5.4.2 Strategic choices 476
15.1.5.4.3 Weaknesses and competitive threats 476
15.1.6 ARLA FOODS AMBA 477
15.1.6.1 Business overview 477
15.1.6.2 Products offered 478
15.1.6.3 Recent developments 480
15.1.6.3.1 Product launches 480
15.1.6.3.2 Deals 481
15.1.6.3.3 Expansions 483
15.1.6.3.4 Other developments 484
15.1.6.4 MnM view 485
15.1.7 DSM-FIRMENICH 486
15.1.7.1 Business overview 486
15.1.7.2 Products offered 487
15.1.7.3 Recent developments 494
15.1.7.3.1 Product launches 494
15.1.7.3.2 Deals 496
15.1.7.3.3 Expansions 497
15.1.7.3.4 Other developments 499
15.1.7.4 MnM view 500
15.1.8 INGREDION 501
15.1.8.1 Business overview 501
15.1.8.2 Products offered 502
15.1.8.3 Recent developments 505
15.1.8.3.1 Product launches 505
15.1.8.3.2 Deals 507
15.1.8.3.3 Expansions 508
15.1.8.3.4 Other developments 508
15.1.8.4 MnM view 509
15.1.9 TATE & LYLE 510
15.1.9.1 Business overview 510
15.1.9.2 Recent developments 512
15.1.9.2.1 Product launches 512
15.1.9.2.2 Deals 513
15.1.9.2.3 Expansions 514
15.1.9.2.4 Other developments 515
15.1.9.3 MnM view 515
15.1.10 ROQUETTE FRÈRES 516
15.1.10.1 Business overview 516
15.1.10.2 Products offered 517
15.1.10.3 Recent developments 520
15.1.10.3.1 Product launches 520
15.1.10.3.2 Deals 521
15.1.10.3.3 Expansions 522
15.1.10.3.4 Other developments 522
15.1.10.4 MnM view 523
15.1.11 ASSOCIATED BRITISH FOODS PLC 524
15.1.11.1 Business overview 524
15.1.11.2 Products offered 525
15.1.11.3 Recent developments 528
15.1.11.3.1 Product launches 528
15.1.11.3.2 Deals 529
15.1.11.3.3 Expansions 530
15.1.11.3.4 Other developments 531
15.1.11.4 MnM view 531
15.1.12 FONTERRA CO-OPERATIVE GROUP LIMITED 533
15.1.12.1 Business overview 533
15.1.12.2 Products offered 534
15.1.12.3 Recent developments 538
15.1.12.3.1 Product launches 538
15.1.12.3.2 Deals 538
15.1.12.3.3 Expansions 539
15.1.12.3.4 Other developments 540
15.1.12.4 MnM view 540
15.1.13 KERRY GROUP PLC 541
15.1.13.1 Business overview 541
15.1.13.2 Products offered 542
15.1.13.3 Recent developments 546
15.1.13.3.1 Product launches 546
15.1.13.3.2 Deals 546
15.1.13.3.3 Expansions 548
15.1.13.3.4 Other developments 548
15.1.13.4 MnM view 549
15.1.14 NOVONESIS GROUP 550
15.1.14.1 Business overview 550
15.1.14.2 Products offered 551
15.1.14.3 Recent developments 554
15.1.14.3.1 Product launches 554
15.1.14.3.2 Deals 555
15.1.14.3.3 Expansions 555
15.1.14.3.4 Other developments 556
15.1.14.4 MnM view 557
15.1.15 BALCHEM CORP. 558
15.1.15.1 Business overview 558
15.1.15.2 Products offered 559
15.1.15.3 Recent developments 563
15.1.15.3.1 Product launches 563
15.1.15.3.2 Deals 564
15.1.15.3.3 Expansions 565
15.1.15.3.4 Other developments 566
15.1.15.4 MnM view 567
15.2 OTHER PLAYERS 568
15.2.1 AJINOMOTO CO., INC. 568
15.2.1.1 Business overview 568
15.2.1.2 Products offered 569
15.2.1.3 Recent developments 571
15.2.1.3.1 Deals 571
15.2.1.3.2 Expansions 572
15.2.1.3.3 Other developments 572
15.2.1.4 MnM view 573
15.2.2 DIVI'S LABORATORIES LIMITED 574
15.2.2.1 Business overview 574
15.2.2.2 Products offered 575
15.2.2.3 Recent developments 578
15.2.2.3.1 Deals 578
15.2.2.3.2 Expansions 578
15.2.2.4 MnM view 579
15.2.3 KEMIN INDUSTRIES, INC. 580
15.2.3.1 Business overview 580
15.2.3.2 Products offered 581
15.2.3.3 Recent developments 582
15.2.3.3.1 Product launches 582
15.2.3.3.2 Deals 583
15.2.3.3.3 Other developments 584
15.2.3.4 MnM view 584
15.2.4 GELITA 585
15.2.4.1 Business overview 585
15.2.4.2 Products offered 585
15.2.4.3 Recent developments 587
15.2.4.3.1 Product launches 587
15.2.4.3.2 Deals 588
15.2.4.3.3 Expansions 588
15.2.4.3.4 Other developments 589
15.2.4.4 MnM view 589
15.2.5 BENEO 590
15.2.5.1 Business overview 590
15.2.5.2 Products offered 591
15.2.5.3 Recent developments 592
15.2.5.3.1 Product launches 592
15.2.5.3.2 Deals 593
15.2.5.3.3 Expansions 594
15.2.5.3.4 Other developments 595
15.2.5.4 MnM view 595
15.2.6 COSUCRA 596
15.2.7 CONAGEN, INC. 597
15.2.8 SARSHIKA PHARMACHEM LLP 598
15.2.9 CANURTA NATURALS USA 599
15.2.10 EVANIUM 600
16 RESEARCH METHODOLOGY 601
16.1 RESEARCH DATA 601
16.1.1 SECONDARY DATA 602
16.1.1.1 List of major secondary sources 602
16.1.1.2 Key data from secondary sources 602
16.1.2 PRIMARY DATA 603
16.1.2.1 Key data from primary sources 603
16.1.2.2 Key industry insights 604
16.1.2.3 Breakdown of primaries 604
16.2 MARKET SIZE ESTIMATION 605
16.2.1 BOTTOM-UP APPROACH 605
16.2.2 TOP-DOWN APPROACH 607
16.2.2.1 Approach to estimate market size using top-down analysis 607
16.2.3 SUPPLY-SIDE ANALYSIS 608
16.2.4 DEMAND-SIDE ANALYSIS 608
16.3 DATA TRIANGULATION 610
16.4 RESEARCH ASSUMPTIONS 611
16.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT 611
17 ADJACENT & RELATED MARKETS 612
17.1 INTRODUCTION 612
17.2 LIMITATIONS 612
17.3 PROTEIN INGREDIENTS MARKET 613
17.3.1 MARKET DEFINITION 613
17.3.2 MARKET OVERVIEW 613
17.4 NUTRACEUTICAL GUMMIES MARKET 615
17.4.1 MARKET DEFINITION 615
17.4.2 MARKET OVERVIEW 615
18 APPENDIX 617
18.1 DISCUSSION GUIDE 617
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 622
18.3 CUSTOMIZATION OPTIONS 624
18.4 RELATED REPORTS 624
18.5 AUTHOR DETAILS 625

ページTOPに戻る

List of Tables/Graphs

TABLE 1 USD EXCHANGE RATES, 2021–2025 51.
TABLE 2 NUTRACEUTICAL INGREDIENTS MARKET: PORTER’S FIVE FORCES ANALYSIS 85.
TABLE 3 NUTRACEUTICAL INGREDIENTS MARKET: SUPPLY CHAIN (ECOSYSTEM) 95.
TABLE 4 AVERAGE SELLING PRICE (ASP), BY INGREDIENT TYPE, 2022–2025 (USD/KG) 97.
TABLE 5 AVERAGE SELLING PRICE (ASP), BY REGION, 2022–2025 (USD/KG) 99.
TABLE 6 TOP 10 EXPORTERS OF HS CODE 2936, 2021–2025 (USD MILLION) 102.
TABLE 7 TOP 10 EXPORTERS OF HS CODE 2936, 2021–2025 (K TONS) 103.
TABLE 8 TOP 10 EXPORTERS OF HS CODE 2936, 2021–2025 (USD MILLION) 103.
TABLE 9 TOP 10 IMPORTERS OF HS CODE 2936, 2021–2025 (K TONS) 104.
TABLE 10 NUTRACEUTICAL INGREDIENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2026–2027 104.
TABLE 11 TARIFF IMPACT ON END-USE INDUSTRIES: NUTRACEUTICAL INGREDIENTS MARKET 111.
TABLE 16 INTERNATIONAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 117.
TABLE 17 GLOBAL INDUSTRY STANDARDS IN NUTRACEUTICAL INGREDIENTS MARKET 119.
TABLE 18 SUSTAINABILITY INITIATIVES IN NUTRACEUTICAL INGREDIENTS MARKET 122.
TABLE 19 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 123.
TABLE 20 CERTIFICATION FOR NUTRACEUTICAL INGREDIENTS MARKET 125.
TABLE 21 LABELING FOR NUTRACEUTICAL INGREDIENTS MARKET 126.
TABLE 22 ECO-STANDARDS FOR NUTRACEUTICAL INGREDIENTS MARKET 127.
TABLE 23 LIST OF MAJOR PATENTS IN NUTRACEUTICAL INGREDIENTS MARKET, 2021–2026 135.
TABLE 24 TOP USE CASES AND MARKET POTENTIAL 138.
TABLE 25 BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES 138.
TABLE 26 NUTRACEUTICAL INGREDIENTS MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION 139.
TABLE 27 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 140.
TABLE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY APPLICATION 146.
TABLE 29 KEY BUYING CRITERIA, BY APPLICATION 148.
TABLE 30 UNMET NEEDS IN NUTRACEUTICAL INGREDIENTS MARKET, BY END-USE INDUSTRY 150.
TABLE 31 NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION) 160.
TABLE 32 NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION) 160.
TABLE 33 NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS) 161.
TABLE 34 NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS) 161.
TABLE 35 FUNCTIONAL PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 162.
TABLE 36 FUNCTIONAL PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 163.
TABLE 37 FUNCTIONAL PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS) 163.
TABLE 38 FUNCTIONAL PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS) 163.
TABLE 39 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 164.
TABLE 40 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 165.
TABLE 41 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS) 165.
TABLE 42 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS) 165.
TABLE 43 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 166.
TABLE 44 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 167.
TABLE 45 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS) 167.
TABLE 46 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS) 167.
TABLE 47 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 168.
TABLE 48 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 169.
TABLE 49 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS) 169.
TABLE 50 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS) 169.
TABLE 51 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 170.
TABLE 52 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 171.
TABLE 53 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS) 171.
TABLE 54 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS) 171.
TABLE 55 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 172.
TABLE 56 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 173.
TABLE 57 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS) 173.
TABLE 58 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS) 173.
TABLE 59 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2022–2025 (USD MILLION) 174.
TABLE 60 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2026–2031 (USD MILLION) 174.
TABLE 61 VITAMIN A: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 175.
TABLE 62 VITAMIN A: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 175.
TABLE 63 VITAMIN B: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 176.
TABLE 64 VITAMIN B: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 176.
TABLE 65 VITAMIN C: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 177.
TABLE 66 VITAMIN C: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 177.
TABLE 67 VITAMIN D: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 178.
TABLE 68 VITAMIN D: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 178.
TABLE 69 VITAMIN E: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 179.
TABLE 70 VITAMIN E: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 179.
TABLE 71 OTHER VITAMINS (MULTIVITAMIN, ETC.): NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 180.
TABLE 72 OTHER VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 180.
TABLE 73 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 181.
TABLE 74 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 181.
TABLE 75 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS) 182.
TABLE 76 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS) 182.
TABLE 77 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2022–2025 (USD MILLION) 182.
TABLE 78 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2026–2031 (USD MILLION) 183.
TABLE 79 CALCIUM: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 184.
TABLE 80 CALCIUM: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 184.
TABLE 81 MAGNESIUM: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 185.
TABLE 82 MAGNESIUM: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 185.
TABLE 83 IRON: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 186.
TABLE 84 IRON: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 186.
TABLE 85 ZINC: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 187.
TABLE 86 ZINC: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 187.
TABLE 87 OTHER MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 188.
TABLE 88 OTHER MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 188.
TABLE 89 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 189.
TABLE 90 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 189.
TABLE 91 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS) 190.
TABLE 92 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS) 190.
TABLE 93 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2022–2025 (USD MILLION) 190.
TABLE 94 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2026–2031 (USD MILLION) 191.
TABLE 95 BRANCHED-CHAIN AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 191.
TABLE 96 BRANCHED-CHAIN AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 192.
TABLE 97 ESSENTIAL AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 192.
TABLE 98 ESSENTIAL AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 193.
TABLE 99 NON-ESSENTIAL AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 194.
TABLE 100 NON-ESSENTIAL AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 194.
TABLE 101 SPECIALTY AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 195.
TABLE 102 SPECIALTY AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 195.
TABLE 103 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 196.
TABLE 104 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 196.
TABLE 105 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS) 197.
TABLE 106 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS) 197.
TABLE 107 OTHER INGREDIENT TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 198.
TABLE 108 OTHER INGREDIENT TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 198.
TABLE 109 OTHER INGREDIENT TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS) 199.
TABLE 110 OTHER INGREDIENT TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS) 199.
TABLE 111 NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2022–2025 (USD MILLION) 202.
TABLE 112 NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2026–2031 (USD MILLION) 202.
TABLE 113 PLANT-BASED: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 203.
TABLE 114 PLANT-BASED: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 203.
TABLE 115 ANIMAL-BASED: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 205.
TABLE 116 ANIMAL-BASED: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 205.
TABLE 117 MICROBIAL-BASED: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 206.
TABLE 118 MICROBIAL-BASED: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 207.
TABLE 119 SYNTHETICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 208.
TABLE 120 SYNTHETICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 208.
TABLE 121 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 211.
TABLE 122 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 211.
TABLE 123 HUMAN NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 212.
TABLE 124 HUMAN NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 212.
TABLE 125 HUMAN NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2022–2025 (USD MILLION) 213.
TABLE 126 HUMAN NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2026–2031 (USD MILLION) 213.
TABLE 127 DIETARY SUPPLEMENTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 214.
TABLE 128 DIETARY SUPPLEMENTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 214.
TABLE 129 FUNCTIONAL FOODS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 215.
TABLE 130 FUNCTIONAL FOODS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 215.
TABLE 131 FUNCTIONAL BEVERAGES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 216.
TABLE 132 FUNCTIONAL BEVERAGES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 216.
TABLE 133 MEDICAL & SPECIALIZED NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 217.
TABLE 134 MEDICAL & SPECIALIZED NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 217.
TABLE 135 INFANT & EARLY-LIFE NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 218.
TABLE 136 INFANT & EARLY-LIFE NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 218.
TABLE 137 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 219.
TABLE 138 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 219.
TABLE 139 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2022–2025 (USD MILLION) 219.
TABLE 140 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2026–2031 (USD MILLION) 220.
TABLE 141 COMPANION ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 220.
TABLE 142 COMPANION ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 221.
TABLE 143 LIVESTOCK NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 221.
TABLE 144 LIVESTOCK NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 222.
TABLE 145 AQUACULTURE NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 222.
TABLE 146 AQUACULTURE NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 223.
TABLE 147 OTHER ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 223.
TABLE 148 OTHER ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 224.
TABLE 149 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 227.
TABLE 150 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 228.
TABLE 151 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2025 (TONS) 228.
TABLE 152 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026–2031 (TONS) 228.
TABLE 153 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 230.
TABLE 154 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2026–2031 (USD MILLION) 231.
TABLE 155 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2025 (TONS) 231.
TABLE 156 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2026–2031 (TONS) 231.
TABLE 157 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION) 232.
TABLE 158 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION) 232.
TABLE 159 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS) 233.
TABLE 160 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS) 233.
TABLE 161 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION) 234.
TABLE 162 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION) 234.
TABLE 163 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION) 234.
TABLE 164 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION) 235.
TABLE 165 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION) 235.
TABLE 166 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION) 235.
TABLE 167 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2022–2025 (USD MILLION) 236.
TABLE 168 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2026–2031 (USD MILLION) 236.
TABLE 169 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 236.
TABLE 170 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 236.
TABLE 171 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION) 237.
TABLE 172 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION) 237.
TABLE 173 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION) 237.
TABLE 174 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION) 238.
TABLE 175 US: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION) 239.
TABLE 176 US: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION) 239.
TABLE 177 US: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS) 240.
TABLE 178 US: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS) 240.
TABLE 179 US: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION) 241.
TABLE 180 US: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION) 241.
TABLE 181 US: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION) 241.
TABLE 182 US: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION) 242.
TABLE 183 US: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION) 242.
TABLE 184 US: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION) 242.
TABLE 185 US: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 243.
TABLE 186 US: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 243.
TABLE 187 US: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION) 243.
TABLE 188 US: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION) 244.
TABLE 189 US: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION) 244.
TABLE 190 US: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION) 244.
TABLE 191 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION) 245.
TABLE 192 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION) 246.
TABLE 193 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS) 246.
TABLE 194 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS) 247.
TABLE 195 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION) 247.
TABLE 196 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION) 248.
TABLE 197 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION) 248.
TABLE 198 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION) 248.
TABLE 199 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION) 249.
TABLE 200 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION) 249.
TABLE 201 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 249.
TABLE 202 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 249.
TABLE 203 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION) 250.
TABLE 204 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION) 250.
TABLE 205 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION) 250.
TABLE 206 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION) 251.
TABLE 207 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION) 252.
TABLE 208 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION) 252.
TABLE 209 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS) 253.
TABLE 210 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS) 253.
TABLE 211 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION) 254.
TABLE 212 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION) 254.
TABLE 213 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION) 254.
TABLE 214 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION) 255.
TABLE 215 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION) 255.
TABLE 216 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION) 255.
TABLE 217 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 256.
TABLE 218 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 256.
TABLE 219 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION) 256.
TABLE 220 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION) 257.
TABLE 221 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION) 257.
TABLE 222 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION) 257.
TABLE 223 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 258.
TABLE 224 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2026–2031 (USD MILLION) 259.
TABLE 225 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2025 (TONS) 259.
TABLE 226 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2026–2031 (TONS) 259.
TABLE 227 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION) 260.
TABLE 228 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION) 260.
TABLE 229 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS) 261.
TABLE 230 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS) 261.
TABLE 231 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION) 262.
TABLE 232 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION) 262.
TABLE 233 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION) 262.
TABLE 234 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION) 263.
TABLE 235 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION) 263.
TABLE 236 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION) 263.
TABLE 237 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2022–2025 (USD MILLION) 264.
TABLE 238 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2026–2031 (USD MILLION) 264.
TABLE 239 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 264.
TABLE 240 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 264.
TABLE 241 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION) 265.
TABLE 242 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION) 265.
TABLE 243 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION) 265.
TABLE 244 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION) 266.
TABLE 245 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION) 267.
TABLE 246 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION) 267.
TABLE 247 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS) 268.
TABLE 248 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS) 268.
TABLE 249 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION) 269.
TABLE 250 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION) 269.
TABLE 251 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION) 269.
TABLE 252 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION) 270.
TABLE 253 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION) 270.
TABLE 254 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION) 270.
TABLE 255 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 271.
TABLE 256 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 271.
TABLE 257 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION) 271.
TABLE 258 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION) 272.
TABLE 259 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION) 272.
TABLE 260 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION) 272.
TABLE 261 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION) 273.
TABLE 262 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION) 274.
TABLE 263 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS) 274.
TABLE 264 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS) 275.
TABLE 265 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION) 275.
TABLE 266 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION) 276.
TABLE 267 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION) 276.
TABLE 268 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION) 276.
TABLE 269 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION) 277.
TABLE 270 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION) 277.
TABLE 271 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 277.
TABLE 272 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 277.
TABLE 273 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION) 278.
TABLE 274 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION) 278.
TABLE 275 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION) 278.
TABLE 276 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION) 279.
TABLE 277 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION) 280.
TABLE 278 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION) 280.
TABLE 279 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS) 281.
TABLE 280 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS) 281.
TABLE 281 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION) 282.
TABLE 282 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION) 282.
TABLE 283 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION) 282.
TABLE 284 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION) 283.
TABLE 285 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION) 283.
TABLE 286 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION) 283.
TABLE 287 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 284.
TABLE 288 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 284.
TABLE 289 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION) 284.
TABLE 290 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION) 285.
TABLE 291 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION) 285.
TABLE 292 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION) 285.
TABLE 293 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION) 286.
TABLE 294 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION) 287.
TABLE 295 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS) 287.
TABLE 296 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS) 288.
TABLE 297 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION) 288.
TABLE 298 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION) 288.
TABLE 299 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION) 289.
TABLE 300 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION) 289.
TABLE 301 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION) 289.
TABLE 302 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION) 290.
TABLE 303 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 290.
TABLE 304 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 290.
TABLE 305 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION) 290.
TABLE 306 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION) 291.
TABLE 307 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION) 291.
TABLE 308 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION) 291.
TABLE 309 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION) 292.
TABLE 310 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION) 293.
TABLE 311 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS) 293.
TABLE 312 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS) 294.
TABLE 313 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION) 294.
TABLE 314 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION) 295.
TABLE 315 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION) 295.
TABLE 316 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION) 295.
TABLE 317 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION) 296.
TABLE 318 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION) 296.
TABLE 319 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 296.
TABLE 320 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 296.
TABLE 321 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION) 297.
TABLE 322 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION) 297.
TABLE 323 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022–2025 (USD MILLION) 297.
TABLE 324 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026–2031 (USD MILLION) 298.
TABLE 325 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (USD MILLION) 299.
TABLE 326 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (USD MILLION) 299.
TABLE 327 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022–2025 (TONS) 300.
TABLE 328 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026–2031 (TONS) 300.
TABLE 329 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022–2025 (USD MILLION) 301.
TABLE 330 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026–2031 (USD MILLION) 301.
TABLE 331 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022–2025 (USD MILLION) 301.
TABLE 332 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026–2031 (USD MILLION) 302.
TABLE 333 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022–2025 (USD MILLION) 302.
TABLE 334 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026–2031 (USD MILLION) 302.
TABLE 335 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 303.
TABLE 336 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 303.
TABLE 337 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022–2025 (USD MILLION) 303.
TABLE 338 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026–2031 (USD MILLION) 304.
TABLE 339 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET